+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

JOHN VOIGHT MEMORIAL LEUKEMIA RESEARCH GRANT

Kids Beating Cancer

Named after Kids Beating Cancer Founder’s son, John Voight, who lost his life to AML Monosomy 7 at the age of nine, the John Voight Memorial Leukemia Research Grant aims to bring today’s leukemia discoveries to the bedside by developing new treatments for pediatric leukemia with emphasis on Acute Myelocytic Leukemia (AML). The John Voight Memorial Leukemia Research Grant funds translational pediatric leukemia research with an emphasis on AML in a two-step format totaling up to $300,000 over a three-year period. The aim of this award is to fund translation studies that support therapeutic development, biomarker research, or any other projects that will have the ability to impact pediatric AML patients within several years.

Apply for the Robert G. Owens Memorial Leukemia Research Grant if your project is geared toward translational research in other childhood leukemias.

Tier 1: $100,000
- Goal: support translational pediatric leukemia research with emphasis on Acute Myelocytic Leukemia (AML)
- Length: 1 year
Tier 2: $200,000
- Eligibility: Tier 1 recipient with successful data
- Length: 2 years

Application Timeline

A letter of intent must be received by the submission deadline indicating interest in applying for the John Voight Memorial Leukemia Research Grant. If invited, a full proposal must be submitted by the specific cycle deadline that meets all Kids Beating Cancer guidelines and criteria to be accepted and reviewed by the Kids Beating Cancer Scientific Advisory Board. All Letters of Intent and applications must be received via Proposal Central.

Letter of Intent Submission Due Date: July 3, 2026
Invitation to Apply notification: September 4, 2026
Proposal Submission: October 16, 2026
Grant award notification: December 2026 – January 2027

AI Based Application Success Predictor

🧒 1. Strong Focus on Pediatric Cancer (Non-Negotiable)

Projects must directly address:
- Childhood cancers
Strong emphasis on:
- Patients undergoing bone marrow / stem cell transplantation

👉 Adult oncology or indirect pediatric relevance → low success probability

🩸 2. Emphasis on Bone Marrow Transplantation & Cellular Therapy (Top Predictor)

Core mission includes:
- Advancing blood and marrow transplant (BMT) care
High-priority areas:
- Transplant outcomes
- Donor matching
- Post-transplant complications

👉 BMT-focused proposals have the highest success rates

🎯 3. Clear Clinical Impact & Survival Benefit (Critical)

Successful proposals:

Demonstrate:
- Improved survival or treatment success
Focus on:
- Cure rates
- Reducing relapse
- Improving transplant success

👉 Key question:
“Will this help more children survive cancer?”

🔄 4. Translational & Clinical Research Focus

Preference for:
- Directly applicable research
Includes:
- Clinical protocols
- Translational immunotherapy
- Supportive care strategies

👉 Pure basic science is less competitive unless clearly linked to treatment

⚡ 5. Addressing High-Risk or Relapsed Pediatric Cancers

Priority given to:
- Hard-to-treat cases
Includes:
- Relapsed leukemia
- Rare pediatric malignancies

👉 High unmet need = higher success probability

🚀 6. Innovation in Treatment Approaches

Encourages:
- Novel therapies
- Improved transplant techniques
- Immunotherapy approaches

👉 Innovation must be clinically actionable

👩‍⚕️ 7. Clinical Environment & Investigator Capability

Strong preference for:
- Investigators affiliated with:
  - Pediatric oncology centers
  - Transplant programs

👉 Access to patients and infrastructure is critical

🤝 8. Collaboration with Clinical Programs & Networks

Successful proposals often involve:
- Multidisciplinary teams
- Clinical collaborators

👉 Team-based care and research strengthen proposals

🧪 9. Feasible, Patient-Focused Study Design

Funding is typically:
- Small to moderate scale
Projects must be:
- Practical
- Deliverable within timeframe

👉 Overly complex proposals are often rejected

📊 10. Direct Benefit to Patients & Families

Unique emphasis on:
- Holistic care and patient support
Includes:
- Quality of life
- Access to treatment

👉 Family-centered outcomes are valued

📊 Summary: Key Predictors (Ranked)

Highest impact factors:

Pediatric cancer focus
Bone marrow transplant relevance
Clinical survival impact

Moderate predictors:
4. Translational relevance
5. High-risk cancer focus
6. Innovation

Supporting factors:
7. Clinical environment
8. Collaboration
9. Feasibility

💡 Insider Insight

Compared to other pediatric cancer funders:

Kids Beating Cancer is:
👉 highly clinical + transplant-focused
👉 strongly oriented toward immediate patient benefit

👉 Key evaluation question:
“Will this improve survival and outcomes for children undergoing cancer treatment—especially transplant?”

✔️ What wins:

BMT/immunotherapy-focused research
High-risk pediatric cancer projects
Clear survival or outcome benefit

❌ What struggles:

Pure basic science
Non-clinical or indirect impact
Weak feasibility

Specialties

Cancer

Pediatrics

Eligibility Requirements

Research must be original, novel and focus on pediatric leukemia, with an emphasis on AML.
Authors must submit original work that has not been previously published; or, if previously submitted abstracts from recent prominent research conferences, such as ASPHO, ASH, ASCO, or AACR, there must be a noted significant change or advancement to the research to be eligible.
Applicants MAY be involved in other research grants, but there must be clear documentation of mechanisms to avoid scientific and/or budgetary overlap.
Research institutions must be based in the United States and must have nonprofit or academic status.
Applicants must have an MD, PhD, or MD/PhD or equivalent and be appointed as faculty (or equivalent) at an academic institution. Post doctoral researchers are eligible to apply.

Sponsor Details

Sponsor Institute/Organizations: Kids Beating Cancer

Sponsor Type: Corporate/Non-Profit

Address: 1720 Lee Road, Winter Park, FL 32789 Tel: 407.894.2888 Toll-Free Number: 866.800.HOPE (4673)

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity